Investigating how EGFR signaling affects osteoarthritis and its treatment
EGFR signaling in osteoarthritis and treatment
This study is looking at how a specific protein called EGFR affects joint health in people with osteoarthritis, using mice to find out if it can help improve cartilage and lead to new treatments for managing or preventing the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10891459 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of epidermal growth factor receptor (EGFR) signaling in osteoarthritis (OA), a common degenerative joint disease. The study utilizes mouse models to explore how changes in EGFR activity impact cartilage health and the progression of OA. By examining the mechanisms behind cartilage degradation and the potential for EGFR to influence cartilage repair, the research aims to identify new therapeutic strategies for OA. Patients may benefit from insights gained that could lead to innovative treatments for managing or preventing OA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from osteoarthritis, particularly those experiencing significant joint pain and disability.
Not a fit: Patients with osteoarthritis who are not responsive to EGFR-related therapies or those with advanced joint degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or reverse the progression of osteoarthritis.
How similar studies have performed: Previous research has shown promising results in targeting EGFR signaling pathways for cartilage health, indicating potential for success in this approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Qin, Ling — University of Pennsylvania
- Study coordinator: Qin, Ling
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.